TY - JOUR
T1 - Synthesis, Structural and Biological Studies of Some Half-Sandwich d6-Metal Complexes with Pyrimidine-Based Ligands
AU - Aradhyula, Basava Punna Rao
AU - Kalidasan, Mahesh
AU - Gangele, Krishnakant
AU - Deb, Debojit K.
AU - Shepherd, Samantha
AU - Phillips, Roger
AU - Poluri, Krishna Mohan
AU - Kollipara, Mohan Rao
PY - 2017/2/23
Y1 - 2017/2/23
N2 - The reaction of metal precursors {[Cp*MCl2]2 (M=Rh, Ir)} with 2-aminopyrimidine (L1) gave binuclear complexes as [(Cp*MCl2)2(μ-L1)], where L1 acted as a bridging ligand. While 2-mercaptopyrimidine (L2) with [Cp*MCl2]2 {M=Rh(III), Ir(III)} formed mononuclear di substituted complexes as [Cp*M(L2)2], where L2 acted as a chelating as well as a monodentate ligand. The reaction of [CpRu(PPh3)2Cl] with 2-mercaptopyrimidine (L2) led to the formation of mononuclear complex as general formula [CpRu(PPh3)(L2)] in presence of a base. 2-Mercaptopyrimidine ligand resulted complexes with strained four-membered metallacycle while 2-aminopyrimidine yielded bridged complexes. HOMO-LUMO energy gaps and UV-Visible bands were additionally rationalised by the DFT studies. The binding ability of the complexes to the CT-DNA was confirmed using UV-Visible and fluorescence spectroscopy. In vitro antibacterial activity of the complexes was evaluated against human pathogenic bacteria. Cytotoxicity of the complexes was examined by the MTT assay over three cancerous and one non-cancer cell lines viz., BE, HT-29, MIA−Pa-Ca2 and ARPE-19.
AB - The reaction of metal precursors {[Cp*MCl2]2 (M=Rh, Ir)} with 2-aminopyrimidine (L1) gave binuclear complexes as [(Cp*MCl2)2(μ-L1)], where L1 acted as a bridging ligand. While 2-mercaptopyrimidine (L2) with [Cp*MCl2]2 {M=Rh(III), Ir(III)} formed mononuclear di substituted complexes as [Cp*M(L2)2], where L2 acted as a chelating as well as a monodentate ligand. The reaction of [CpRu(PPh3)2Cl] with 2-mercaptopyrimidine (L2) led to the formation of mononuclear complex as general formula [CpRu(PPh3)(L2)] in presence of a base. 2-Mercaptopyrimidine ligand resulted complexes with strained four-membered metallacycle while 2-aminopyrimidine yielded bridged complexes. HOMO-LUMO energy gaps and UV-Visible bands were additionally rationalised by the DFT studies. The binding ability of the complexes to the CT-DNA was confirmed using UV-Visible and fluorescence spectroscopy. In vitro antibacterial activity of the complexes was evaluated against human pathogenic bacteria. Cytotoxicity of the complexes was examined by the MTT assay over three cancerous and one non-cancer cell lines viz., BE, HT-29, MIA−Pa-Ca2 and ARPE-19.
U2 - 10.1002/slct.201601926
DO - 10.1002/slct.201601926
M3 - Article
VL - 2
SP - 2065
EP - 2076
JO - ChemistrySelect
JF - ChemistrySelect
SN - 2365-6549
IS - 6
ER -